Abstract
To the Editor:— Dr. Baer's communication toThe Journal, January 17, commenting on our article Sudden Death of Patients with Few Symptoms of Heart Disease interests us very much because it represents the fairly typical reaction of some physicians when confronted by a proposed therapeutic regimen whose basis is physiologic experimentation. The objections offered to the use of theophylline with ethylene diamine intravenously are: However, feel it is not entirely just to develop the (proposed) therapeutic regimen in man; There are a number of additional reasons why think the routine administration of theophylline with ethylene diamine (aminophylline) and atropine is inadvisable; I believe a patient with an acute myocardial infarct should have as little intravenous medication as possible. These are not very logical objections. It is recognized by most physicians that a powerful vasodilating drug should be given intravenously with caution to any patient, and particularly when
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
